BMC Cancer (Aug 2005)

Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis

  • Rom William N,
  • Greenberg Alissa K,
  • Qiu Ji,
  • Misek David E,
  • Orchekowski Randal P,
  • Kuick Rork,
  • Gao Wei-Min,
  • Brenner Dean E,
  • Omenn Gilbert S,
  • Haab Brian B,
  • Hanash Samir M

DOI
https://doi.org/10.1186/1471-2407-5-110
Journal volume & issue
Vol. 5, no. 1
p. 110

Abstract

Read online

Abstract Background Cancer serum protein profiling by mass spectrometry has uncovered mass profiles that are potentially diagnostic for several common types of cancer. However, direct mass spectrometric profiling has a limited dynamic range and difficulties in providing the identification of the distinctive proteins. We hypothesized that distinctive profiles may result from the differential expression of relatively abundant serum proteins associated with the host response. Methods Eighty-four antibodies, targeting a wide range of serum proteins, were spotted onto nitrocellulose-coated microscope slides. The abundances of the corresponding proteins were measured in 80 serum samples, from 24 newly diagnosed subjects with lung cancer, 24 healthy controls, and 32 subjects with chronic obstructive pulmonary disease (COPD). Two-color rolling-circle amplification was used to measure protein abundance. Results Seven of the 84 antibodies gave a significant difference (p Conclusion Our results suggest that a distinctive serum protein profile involving abundant proteins may be observed in lung cancer patients relative to healthy subjects or patients with chronic disease and may have utility as part of strategies for detecting lung cancer.